Last refreshed: September 4, 2026 (US ET)
Back to holdings

ALGN

Growth

ALIGN TECHNOLOGY INC.

Health Care·Health Care Supplies

Align Technology, Inc. provides Invisalign clear aligners, Vivera retainers, and iTero intraoral scanners and services in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers Invisalign comprehensive package to treat adults and teens malocclusion and features, and orthodontic needs of teenage or younger patients; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients between the ages of six and ten years with a mixture of primary/baby and permanent teeth.

Close · 3M

-1.34%

ALGN · 3M

-1.34%

Pinch / wheel to zoom · drag to pan · double-tap to reset

Held by 0 AI ETFs

None of the tracked AI ETFs currently hold this name.

Signal performance

Each tracked ETF's moves on this stock, grouped by fund. Returns are measured from the signal date to the latest close — hypothetical, no commissions or slippage.

Buy signals1
Win rate100% (1/1)
Avg buy return+0.34%
AIEQno longer held7 signals

AIEQ · Exit · 1d

weight 0.080% → 0 (exited)·stock up 6.9% in the 30 days before

Jul 1·entry $181.49·now $172.46

-4.98%
since Jul 1

AIEQ · Weight decrease · 2d

weight 0.640% → 0.080% (-0.560 pp)·stock down 1.9% in the 30 days before

May 30·entry $169.77·now $172.46

+1.58%
since May 30

AIEQ · Weight decrease · 4d

weight 0.670% → 0.620% (-0.050 pp)·stock down 15.0% in the 30 days before

May 17·entry $158.78·now $172.46

+8.62%
since May 17

AIEQ · Weight decrease · 3d

weight 0.670% → 0.630% (-0.040 pp)·stock down 15.0% in the 30 days before

May 15·entry $157.25·now $172.46

+9.67%
since May 15

AIEQ · Weight decrease · 2d

weight 0.670% → 0.640% (-0.030 pp)·stock down 13.9% in the 30 days before

May 14·entry $160.53·now $172.46

+7.43%
since May 14

AIEQ · Weight decrease · 2d

weight 0.720% → 0.680% (-0.040 pp)·stock up 4.2% in the 30 days before

May 6·entry $173.94·now $172.46

-0.85%
since May 6

AIEQ · New entry · 1d

weight 0 → 0.720% (new)·stock up 3.6% in the 30 days before

May 3·entry $171.88·now $172.46Fresh

+0.34%
since May 3

Sell signals show what the stock did after the AI exited. A negative number means the AI's exit was well-timed.

Buffett-style framework

Fails the frameworkas of Jul 5

The AI ETF AIEQ's recent exit from Align Technology on 2026-07-01 aligns with this analysis's "Fail" verdict. This suggests the AI's algorithm may also be factoring in concerns about the company's valuation or financial health.

  • Circle of CompetenceThe unit economics of dental aligners and scanners, while involving technological evolution, are stable enough to reasonably project future cash flows within a value investor's circle of competence.
  • Economic MoatAlign Technology benefits from strong brand recognition (Invisalign), significant switching costs for dental professionals, and scale advantages as a market leader, contributing to a durable economic moat.
  • ManagementThe provided data does not offer sufficient information to assess management's candidness, capital allocation discipline, or extent of skin in the game.
  • Financial HealthWhile the current ROE of 10.7% meets the single-year minimum, the absence of data on the 10-year average ROE, operating margin stability, and debt levels makes a full assessment of financial health impossible based on the framework's criteria.
  • Margin of SafetyWith a P/E of 30.79 and EV/EBITDA of 20.89 alongside modest revenue growth and current ROE, the current price offers no defensible margin of safety.

While Align Technology operates within a predictable industry and possesses a durable economic moat, an evaluation using this framework raises significant concerns regarding its financial health and current valuation. The lack of sufficient data on management and the company's inability to clearly meet financial health criteria, combined with a high price relative to its current growth and returns, leads to an overall "Fail" verdict.

Educational interpretation generated by AI applying frameworks Warren Buffett documented in his shareholder letters and other public writings. Not a statement by Mr. Buffett or Berkshire Hathaway, and not investment advice.